Hope springs eternal,where as faith in this science is the key to an early retirement. 3 bucks a share,with a potential of 120-300,unless Amgn or Merck decides to strike before approval. If that happens,depending on how soon before approval,,it could be less than the 120.00 a share,obviously. In no way though will this company be had for less 3-4 billion,unless it happens before the new year,and that`s not likely. My 60.00 a share number is never gonna happen now,,sorry I ever even mentioned it,but with all the 10-20 dollar buyout rants,I had to keep it somewhat close to their dilusional Idea of reality.
Market Data 
Markets 
AI
